ASH PR highlights TI patients previously treated with Luspatercept

Forum rules
- Comments must be civil and on topic
- Back up claims with evidence/reasoning/sources (posting links is allowed)
- No commercials/harassment/spam
Post Reply
kmall
Posts: 753
Joined: Thu Mar 21, 2019 3:57 pm

ASH PR highlights TI patients previously treated with Luspatercept

Post by kmall » Mon Dec 12, 2022 2:46 pm

In patients previously treated with luspatercept, 33% achieved 1-year TI

"New efficacy data related to the 16% (6/38) of patients in IMerge Phase 2 who were relapsed/refractory to ESAs and had also been treated previously with luspatercept are as follows:

50% (3/6) of these patients achieved ≥8-week TI
67% (2/3) of those ≥8-week TI responders also achieved ≥24-week TI
100% (2/2) of those ≥24-week TI responders also achieved >1 year TI"


https://ir.geron.com/investors/press-re ... fault.aspx

Post Reply